KD Logo

Teva- Pharmaceutical Industries Ltd. ADR [TEVA] Shareholder makes an insider purchase of 286,000 shares worth 6.09 million.

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Teva- Pharmaceutical Industries Ltd. ADR shares valued at $6,094,660 were purchased by Bridger Management, LLC (1) on Dec 20 ’24. At $21.31 per share, Bridger Management, LLC (1) acquired 286,000 shares.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Also, Fox Christine sold 19,388 shares, netting a total of over 327,085 in proceeds. Following the sale of shares at $16.87 each, the insider now holds 44,104 shares.

Before that, Fox Christine had added 19,388 shares to its account. In a trade valued at $327,085, the Officer bought Teva- Pharmaceutical Industries Ltd. ADR shares for $16.87 each.

As published in a research note from Argus on July 10, 2024, Teva- Pharmaceutical Industries Ltd. ADR [TEVA] has been rated up from a Hold to a Buy and the price target has been revised to $20. Analysts at JP Morgan upgraded the stock from ‘”an Underweight”‘ to ‘”a Neutral”‘ outlook in a report released in early March. As of February 12, 2024, Piper Sandler has increased its “Neutral” rating to a “an Overweight” for TEVA. Earlier on January 23, 2024, Jefferies upgraded its rating. Their new recommendation was “a Buy” for TEVA stock which previously was a “a Hold”.

Analyzing TEVA Stock Performance

During the last five days, there has been a surge of approximately 7.42%. Over the course of the year, Teva- Pharmaceutical Industries Ltd. ADR shares have jumped approximately 114.85%. Shares of the company reached a 52-week high of $22.50 on 12/24/24 and a 52-week low of $10.45 on 01/02/24. A 50-day SMA is recorded $18.00, while a 200-day SMA reached $16.72. Nevertheless, trading volume fell to 3.03 million shares from 7.44 million shares the previous day.

Support And Resistance Levels for Teva- Pharmaceutical Industries Ltd. ADR (TEVA)

According to the 24-hour chart, there is a support level at 22.24, which, if violated, would cause prices to drop to 22.06. In the upper region, resistance lies at 22.55. The next price resistance is at 22.68. RSI (Relative Strength Index) is 79.15 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 3.13, which suggests the price will increase in the coming days. Percent R is at 1.28%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.

Most Popular